Camp4 Therapeutics CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
CAMP4 Therapeutics Corporation announces its 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026, with key proposals including director elections and an amendment to its equity incentive plan.
NASDAQ
Camp4 Therapeutics Corporation has filed a definitive proxy statement with the SEC regarding its upcoming 2025 annual meeting.
NASDAQ
CAMP4 Therapeutics Corporation will hold its 2025 annual meeting of stockholders virtually on June 11, 2025, to elect directors and ratify the appointment of its independent accounting firm.